Skip to main content
Equibles

Bonnie Anderson

Equibles does not estimate personal net worth.

About Bonnie Anderson

Bonnie Anderson was last confirmed as CEO and Board Member at Veracyte, Inc. (VCYT) in a filing dated April 26, 2022. The proxy statement of Veracyte, Inc. reports total compensation of $4,518,093 for Bonnie Anderson in fiscal 2021, including a base salary of $650,000. Disclosed compensation is on record for 5 fiscal years. Bonnie Anderson has spoken on 6 earnings calls across 1 company, most recently for Veracyte, Inc. on July 29, 2021. The companies whose calls Bonnie Anderson spoke on are classified in the Healthcare sector.

Bonnie Anderson on recent calls

“I would like to take a moment to thank the Veracyte team for their incredible focus that led to tremendous accomplishments in Q2. I am so proud of the team and could not be more pleased now to have Marc at the helm of Veracyte.”
Chairman, Veracyte, Inc. Q2 FY2021 Earnings Call ·
“Before we get into the strong progress we made in the first quarter, I will begin with the CEO succession plan that we announced a few minutes ago.”
CEO, Veracyte, Inc. Q1 FY2021 Earnings Call ·
“Despite the pandemic headwinds, we closed 2020 with strong momentum across the business and are on track to launch multiple products in 2021, including our non-invasive nasal swab test and Percepta Genomic Atlas in lung cancer, and we now have a new general manager base structure in place to drive our business forward.”
CEO, Veracyte, Inc. Q4 FY2020 Earnings Call ·
“We achieved impressive results for the third quarter of 2020 across various metrics of success. Our revenue and volumes saw significant increases compared to the previous quarter, returning to pre-pandemic levels ahead of our expected timeline.”
Chairman, Veracyte, Inc. Q3 FY2020 Earnings Call ·
“Thanks, Tracy, and thanks everyone for joining us today as we discuss our second quarter 2020 results and share an update on the business. We are pleased with our second quarter results given the significant challenges from the COVID-19 pandemic.”
Chairman, Veracyte, Inc. Q2 FY2020 Earnings Call ·

Affiliation history

  • Veracyte, Inc. (VCYT)

    Board Member

    Proxy statement

    2008-01-01–2022-04-26

    Last confirmed by a filing; no departure on record

  • Veracyte, Inc. (VCYT)

    CEO

    Proxy statement

    Start not stated–2022-04-26

    Last confirmed by a filing; no departure on record

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Veracyte, Inc. (VCYT) $650,000 $4,518,093
2020 Veracyte, Inc. (VCYT) $625,000 $4,571,345
2019 Veracyte, Inc. (VCYT) $580,000 $4,161,963
2018 Veracyte, Inc. (VCYT) $550,000 $2,831,240
2017 Veracyte, Inc. (VCYT) $550,000 $2,213,128

Recent activity